rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1993-4-30
|
pubmed:abstractText |
A multicenter controlled study was performed to evaluate the effect of high doses of the low molecular weight protease inhibitor gabexate mesilate on mortality and complications associated with moderate and severe acute pancreatitis.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0016-5085
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1165-70
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8462805-Acute Disease,
pubmed-meshheading:8462805-Adult,
pubmed-meshheading:8462805-Aged,
pubmed-meshheading:8462805-Double-Blind Method,
pubmed-meshheading:8462805-Female,
pubmed-meshheading:8462805-Gabexate,
pubmed-meshheading:8462805-Humans,
pubmed-meshheading:8462805-Male,
pubmed-meshheading:8462805-Middle Aged,
pubmed-meshheading:8462805-Pancreatitis,
pubmed-meshheading:8462805-Placebos
|
pubmed:year |
1993
|
pubmed:articleTitle |
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group.
|
pubmed:affiliation |
Department of Surgery, University of Ulm, Germany.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|